Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis.
Riaz IB, Zahid U, Kamal MU, Husnain M, McBride A, Hua A, Hamadani AA, George L, Zeeshan A, Sipra QR, Raina A, Rahman B, Puvvada S, Anwer F.
Riaz IB, et al. Among authors: mcbride a.
Immunotherapy. 2017 Sep;9(12):979-993. doi: 10.2217/imt-2017-0062.
Immunotherapy. 2017.
PMID: 28971751
Free PMC article.
Review.